Jean Esq - CryoLife Gen VP
| CYL Stock | EUR 22.80 0.60 2.70% |
Insider
Jean Esq is Gen VP of CryoLife
| Age | 66 |
| Phone | 770 419 3355 |
| Web | https://artivion.com |
CryoLife Management Efficiency
The company has return on total asset (ROA) of 0.0122 % which means that it generated a profit of $0.0122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0656) %, meaning that it generated substantial loss on money invested by shareholders. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities.CryoLife has accumulated 306.5 M in total debt with debt to equity ratio (D/E) of 98.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CryoLife has a current ratio of 4.93, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CryoLife until it has trouble settling it off, either with new capital or with free cash flow. So, CryoLife's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CryoLife sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CryoLife to invest in growth at high rates of return. When we think about CryoLife's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Samuel III | The Boston Beer | 53 | |
| Carolyn OBoyle | The Boston Beer | 44 | |
| John Geist | The Boston Beer | 63 | |
| Nobuya Kato | Japan Tobacco | N/A | |
| Muneaki Fujimoto | Japan Tobacco | N/A | |
| Kazuhito Yamashita | Japan Tobacco | 60 | |
| James Koch | The Boston Beer | 73 | |
| Mutsuo Iwai | Japan Tobacco | 63 | |
| Naohiro Minami | Japan Tobacco | 59 | |
| Junichi Fukuchi | Japan Tobacco | N/A | |
| Kiyohide Hirowatari | Japan Tobacco | 58 | |
| Osamu Hirose | Japan Tobacco | N/A | |
| Masamichi Terabatake | Japan Tobacco | 58 | |
| Matthew Murphy | The Boston Beer | 54 | |
| Paul Weaver | The Boston Beer | N/A | |
| Tara Heath | The Boston Beer | 48 | |
| Lesya Lysyj | The Boston Beer | 60 | |
| Dinesh Thotakura | Japan Tobacco | N/A | |
| Frank Smalla | The Boston Beer | 57 | |
| David Burwick | The Boston Beer | 61 | |
Management Performance
| Return On Equity | -0.0656 | |||
| Return On Asset | 0.0122 |
CryoLife Leadership Team
Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, VP Officer | ||
| James Mackin, Pres Chairman | ||
| Dennis Maier, VP Operations | ||
| Joshua Wells, Sr Devel | ||
| Marshall MD, VP Officer | ||
| Jean Esq, Gen VP | ||
| John Davis, VP Marketing | ||
| Matthew Getz, VP HR |
CryoLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CryoLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0656 | |||
| Return On Asset | 0.0122 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 796.78 M | |||
| Shares Outstanding | 40.56 M | |||
| Shares Owned By Insiders | 4.69 % | |||
| Shares Owned By Institutions | 87.40 % | |||
| Price To Earning | 303.28 X | |||
| Price To Book | 2.05 X |
Currently Active Assets on Macroaxis
Other Information on Investing in CryoLife Stock
CryoLife financial ratios help investors to determine whether CryoLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CryoLife with respect to the benefits of owning CryoLife security.